Furthermore, this study demonstrates that TPGS-FA/NC suppresses hepatoma cell proliferation and hepatic CSCs, as well as the AQP3/STAT3/CD133 axis and Nek2 expression in offering possible multiple mechanisms for its antitumor activity. The gene discussed is STAT3; the disease is hepatocellular carcinoma.